Concepts (219)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Oropharyngeal Neoplasms | 22 | 2023 | 477 | 6.620 |
Why?
|
Papillomavirus Infections | 25 | 2023 | 1587 | 5.720 |
Why?
|
Head and Neck Neoplasms | 25 | 2024 | 2736 | 5.120 |
Why?
|
Carcinoma, Squamous Cell | 18 | 2024 | 4033 | 2.510 |
Why?
|
Papillomaviridae | 12 | 2023 | 1119 | 2.400 |
Why?
|
Alphapapillomavirus | 4 | 2022 | 221 | 2.010 |
Why?
|
Free Tissue Flaps | 3 | 2024 | 328 | 1.380 |
Why?
|
Salivary Gland Neoplasms | 4 | 2016 | 298 | 1.020 |
Why?
|
DNA, Viral | 8 | 2023 | 2226 | 1.020 |
Why?
|
Carcinoma, Adenoid Cystic | 3 | 2016 | 252 | 1.000 |
Why?
|
Receptor, Notch1 | 2 | 2018 | 502 | 0.920 |
Why?
|
Human papillomavirus 16 | 5 | 2023 | 261 | 0.840 |
Why?
|
Oncogene Proteins, Viral | 2 | 2023 | 362 | 0.820 |
Why?
|
Neoplasms, Unknown Primary | 2 | 2022 | 104 | 0.800 |
Why?
|
Nasolacrimal Duct | 1 | 2022 | 74 | 0.790 |
Why?
|
Tonsillar Neoplasms | 1 | 2021 | 51 | 0.780 |
Why?
|
Sexual Behavior | 3 | 2018 | 2049 | 0.610 |
Why?
|
Oncogene Proteins, Fusion | 2 | 2016 | 1581 | 0.600 |
Why?
|
Electric Power Supplies | 1 | 2018 | 98 | 0.590 |
Why?
|
NFI Transcription Factors | 1 | 2016 | 44 | 0.550 |
Why?
|
Foreign-Body Migration | 1 | 2018 | 222 | 0.530 |
Why?
|
Thoracic Neoplasms | 1 | 2018 | 268 | 0.530 |
Why?
|
Scalp | 1 | 2018 | 378 | 0.500 |
Why?
|
Age Factors | 8 | 2021 | 18355 | 0.470 |
Why?
|
Mouth Neoplasms | 4 | 2024 | 601 | 0.470 |
Why?
|
Middle Ear Ventilation | 1 | 2014 | 94 | 0.460 |
Why?
|
Epidemics | 2 | 2018 | 523 | 0.450 |
Why?
|
Cochlear Implants | 1 | 2018 | 339 | 0.440 |
Why?
|
Gene Rearrangement | 2 | 2016 | 1179 | 0.440 |
Why?
|
Mouth | 1 | 2015 | 374 | 0.440 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2018 | 1114 | 0.420 |
Why?
|
Otitis Media | 1 | 2014 | 277 | 0.410 |
Why?
|
Activities of Daily Living | 1 | 2021 | 2419 | 0.410 |
Why?
|
Hearing Loss, Sensorineural | 1 | 2018 | 770 | 0.400 |
Why?
|
Neoplasm Recurrence, Local | 6 | 2023 | 9239 | 0.380 |
Why?
|
DNA, Neoplasm | 2 | 2015 | 1758 | 0.370 |
Why?
|
Translocation, Genetic | 1 | 2016 | 1420 | 0.360 |
Why?
|
Pain, Postoperative | 1 | 2020 | 1642 | 0.360 |
Why?
|
Middle Aged | 35 | 2024 | 213241 | 0.330 |
Why?
|
Prognosis | 14 | 2023 | 29052 | 0.310 |
Why?
|
Neoplasm Staging | 7 | 2023 | 11036 | 0.300 |
Why?
|
Carcinoma | 2 | 2018 | 2375 | 0.300 |
Why?
|
Cell Cycle Proteins | 1 | 2018 | 3463 | 0.280 |
Why?
|
Smoking Cessation | 1 | 2018 | 2071 | 0.270 |
Why?
|
Humans | 54 | 2024 | 743811 | 0.260 |
Why?
|
Aged | 25 | 2024 | 163178 | 0.250 |
Why?
|
Male | 38 | 2024 | 349776 | 0.250 |
Why?
|
Cutaneous Fistula | 1 | 2014 | 78 | 0.240 |
Why?
|
Analgesics, Opioid | 1 | 2020 | 3677 | 0.230 |
Why?
|
Umbilicus | 1 | 2013 | 41 | 0.230 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2016 | 2018 | 0.230 |
Why?
|
Pharyngeal Diseases | 1 | 2014 | 133 | 0.230 |
Why?
|
Osteoradionecrosis | 1 | 2022 | 49 | 0.210 |
Why?
|
Fistula | 1 | 2014 | 221 | 0.210 |
Why?
|
Female | 36 | 2024 | 380020 | 0.210 |
Why?
|
Laryngectomy | 1 | 2014 | 248 | 0.210 |
Why?
|
Maryland | 3 | 2018 | 276 | 0.200 |
Why?
|
Retrospective Studies | 22 | 2024 | 77410 | 0.200 |
Why?
|
Laryngeal Diseases | 1 | 2014 | 241 | 0.200 |
Why?
|
Laparotomy | 1 | 2013 | 473 | 0.200 |
Why?
|
Parathyroid Hormone | 2 | 2018 | 1800 | 0.190 |
Why?
|
Aged, 80 and over | 10 | 2022 | 57744 | 0.190 |
Why?
|
Palatine Tonsil | 1 | 2021 | 193 | 0.190 |
Why?
|
Risk Factors | 13 | 2021 | 72252 | 0.190 |
Why?
|
Minnesota | 1 | 2020 | 344 | 0.170 |
Why?
|
Pain Measurement | 2 | 2020 | 3420 | 0.170 |
Why?
|
Cleavage And Polyadenylation Specificity Factor | 1 | 2008 | 17 | 0.160 |
Why?
|
RNA 3' End Processing | 1 | 2008 | 17 | 0.160 |
Why?
|
DNA | 2 | 2023 | 7295 | 0.160 |
Why?
|
Tongue | 1 | 2021 | 404 | 0.160 |
Why?
|
Cicatrix | 1 | 2013 | 763 | 0.150 |
Why?
|
Baltimore | 1 | 2018 | 230 | 0.150 |
Why?
|
Disease-Free Survival | 3 | 2021 | 6895 | 0.150 |
Why?
|
Mutation | 3 | 2018 | 29777 | 0.140 |
Why?
|
Precancerous Conditions | 1 | 2024 | 975 | 0.140 |
Why?
|
Parathyroidectomy | 1 | 2018 | 235 | 0.140 |
Why?
|
Incidence | 7 | 2018 | 20948 | 0.140 |
Why?
|
Parathyroid Glands | 1 | 2018 | 509 | 0.140 |
Why?
|
Hyperparathyroidism, Primary | 1 | 2018 | 160 | 0.140 |
Why?
|
Hypocalcemia | 1 | 2017 | 191 | 0.140 |
Why?
|
Anti-Bacterial Agents | 1 | 2014 | 7172 | 0.140 |
Why?
|
Salvage Therapy | 2 | 2021 | 1275 | 0.140 |
Why?
|
Cohort Studies | 4 | 2024 | 40545 | 0.130 |
Why?
|
Radiotherapy, Intensity-Modulated | 1 | 2022 | 806 | 0.130 |
Why?
|
Endonucleases | 1 | 2008 | 380 | 0.130 |
Why?
|
Delayed Diagnosis | 1 | 2019 | 441 | 0.130 |
Why?
|
Carcinoma, Mucoepidermoid | 1 | 2015 | 88 | 0.130 |
Why?
|
Cross-Sectional Studies | 3 | 2022 | 25032 | 0.130 |
Why?
|
Perimenopause | 1 | 2016 | 139 | 0.130 |
Why?
|
Conserved Sequence | 1 | 2008 | 1202 | 0.130 |
Why?
|
Protein Subunits | 1 | 2008 | 959 | 0.120 |
Why?
|
Vocal Cord Paralysis | 1 | 2018 | 267 | 0.120 |
Why?
|
Calcium | 2 | 2018 | 5755 | 0.120 |
Why?
|
Otoscopy | 1 | 2014 | 36 | 0.120 |
Why?
|
Seroepidemiologic Studies | 1 | 2016 | 403 | 0.120 |
Why?
|
Nutrition Surveys | 1 | 2021 | 1660 | 0.120 |
Why?
|
Surgery, Computer-Assisted | 1 | 2022 | 1017 | 0.120 |
Why?
|
Chloride Channels | 1 | 2015 | 227 | 0.120 |
Why?
|
Therapeutic Irrigation | 1 | 2015 | 300 | 0.120 |
Why?
|
Nasopharyngeal Neoplasms | 1 | 2017 | 287 | 0.120 |
Why?
|
SEER Program | 2 | 2016 | 1507 | 0.120 |
Why?
|
Otitis Media with Effusion | 1 | 2014 | 114 | 0.110 |
Why?
|
Laryngeal Neoplasms | 1 | 2017 | 512 | 0.110 |
Why?
|
Postoperative Complications | 3 | 2021 | 15281 | 0.110 |
Why?
|
Device Removal | 1 | 2018 | 655 | 0.110 |
Why?
|
Laryngoscopy | 1 | 2018 | 710 | 0.110 |
Why?
|
RNA, Messenger | 2 | 2016 | 13028 | 0.100 |
Why?
|
Thyroidectomy | 1 | 2017 | 879 | 0.100 |
Why?
|
Monitoring, Intraoperative | 1 | 2018 | 957 | 0.100 |
Why?
|
Follow-Up Studies | 5 | 2018 | 39001 | 0.100 |
Why?
|
Immunoenzyme Techniques | 1 | 2015 | 1799 | 0.100 |
Why?
|
Disabled Persons | 1 | 2021 | 1214 | 0.100 |
Why?
|
Kaplan-Meier Estimate | 3 | 2018 | 6539 | 0.100 |
Why?
|
Thyroid Gland | 1 | 2018 | 1173 | 0.100 |
Why?
|
Receptors, Notch | 1 | 2016 | 739 | 0.100 |
Why?
|
Saliva | 1 | 2015 | 809 | 0.100 |
Why?
|
Survival Analysis | 3 | 2018 | 10251 | 0.090 |
Why?
|
Neoadjuvant Therapy | 1 | 2021 | 2727 | 0.090 |
Why?
|
Epigenomics | 1 | 2015 | 903 | 0.090 |
Why?
|
Counseling | 1 | 2018 | 1523 | 0.090 |
Why?
|
Patient Acceptance of Health Care | 1 | 2023 | 3020 | 0.090 |
Why?
|
Preventive Health Services | 1 | 2014 | 575 | 0.090 |
Why?
|
Program Evaluation | 1 | 2018 | 2483 | 0.090 |
Why?
|
Quality of Life | 2 | 2024 | 12788 | 0.080 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2015 | 2649 | 0.080 |
Why?
|
Pilot Projects | 2 | 2021 | 8316 | 0.080 |
Why?
|
Sex Factors | 5 | 2018 | 10394 | 0.080 |
Why?
|
Sexually Transmitted Diseases | 1 | 2014 | 623 | 0.080 |
Why?
|
Adult | 16 | 2023 | 213889 | 0.080 |
Why?
|
United States | 6 | 2018 | 69859 | 0.080 |
Why?
|
Histones | 1 | 2008 | 2598 | 0.080 |
Why?
|
Socioeconomic Factors | 1 | 2021 | 7784 | 0.070 |
Why?
|
Proportional Hazards Models | 3 | 2018 | 12354 | 0.070 |
Why?
|
Prevalence | 4 | 2018 | 15211 | 0.070 |
Why?
|
Immunohistochemistry | 2 | 2018 | 11360 | 0.070 |
Why?
|
Neoplasm Invasiveness | 1 | 2015 | 3617 | 0.070 |
Why?
|
Recurrence | 2 | 2018 | 8337 | 0.070 |
Why?
|
Case-Control Studies | 2 | 2022 | 21733 | 0.070 |
Why?
|
Diagnosis, Differential | 2 | 2019 | 12954 | 0.070 |
Why?
|
Risk Assessment | 3 | 2018 | 23327 | 0.070 |
Why?
|
Prospective Studies | 2 | 2023 | 53250 | 0.070 |
Why?
|
Survivors | 1 | 2016 | 2291 | 0.070 |
Why?
|
DNA Methylation | 2 | 2016 | 4286 | 0.060 |
Why?
|
Treatment Outcome | 5 | 2021 | 63042 | 0.060 |
Why?
|
Survival Rate | 2 | 2019 | 12786 | 0.060 |
Why?
|
Sequence Analysis, DNA | 1 | 2016 | 4803 | 0.060 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2015 | 2944 | 0.060 |
Why?
|
Adolescent | 4 | 2023 | 85729 | 0.060 |
Why?
|
Signal Transduction | 2 | 2018 | 23398 | 0.060 |
Why?
|
Acute Disease | 1 | 2014 | 7150 | 0.060 |
Why?
|
Leukoplakia, Oral | 1 | 2024 | 73 | 0.060 |
Why?
|
Disease Management | 1 | 2014 | 2459 | 0.060 |
Why?
|
Predictive Value of Tests | 2 | 2018 | 15067 | 0.060 |
Why?
|
Parotid Gland | 1 | 2022 | 168 | 0.050 |
Why?
|
Hospitalization | 1 | 2020 | 10259 | 0.050 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2021 | 11524 | 0.050 |
Why?
|
Tracheostomy | 1 | 2014 | 401 | 0.050 |
Why?
|
Time Factors | 3 | 2018 | 40038 | 0.050 |
Why?
|
Organs at Risk | 1 | 2022 | 346 | 0.040 |
Why?
|
Gene Expression Profiling | 1 | 2016 | 9440 | 0.040 |
Why?
|
Tomography, X-Ray Computed | 2 | 2023 | 20121 | 0.040 |
Why?
|
Disease Progression | 1 | 2015 | 13273 | 0.040 |
Why?
|
Suture Techniques | 1 | 2013 | 797 | 0.040 |
Why?
|
Hemoglobins | 1 | 2014 | 1531 | 0.040 |
Why?
|
Medicare | 1 | 2016 | 6565 | 0.040 |
Why?
|
Infant | 2 | 2014 | 35122 | 0.040 |
Why?
|
Child, Preschool | 2 | 2014 | 40964 | 0.040 |
Why?
|
RNA Precursors | 1 | 2008 | 209 | 0.040 |
Why?
|
Practice Guidelines as Topic | 1 | 2014 | 7270 | 0.040 |
Why?
|
Papillomavirus E7 Proteins | 1 | 2017 | 123 | 0.040 |
Why?
|
Recurrent Laryngeal Nerve | 1 | 2018 | 139 | 0.040 |
Why?
|
Severity of Illness Index | 1 | 2014 | 15526 | 0.040 |
Why?
|
Amino Acid Motifs | 1 | 2008 | 936 | 0.030 |
Why?
|
Surgical Flaps | 1 | 2014 | 1629 | 0.030 |
Why?
|
Radiotherapy Dosage | 1 | 2022 | 2879 | 0.030 |
Why?
|
Qualitative Research | 1 | 2023 | 2682 | 0.030 |
Why?
|
Salivary Glands | 1 | 2016 | 229 | 0.030 |
Why?
|
California | 1 | 2018 | 1402 | 0.030 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2017 | 705 | 0.030 |
Why?
|
Vocal Cords | 1 | 2018 | 528 | 0.030 |
Why?
|
Radiation Dosage | 1 | 2022 | 1928 | 0.030 |
Why?
|
Radiotherapy Planning, Computer-Assisted | 1 | 2022 | 1624 | 0.030 |
Why?
|
Young Adult | 2 | 2018 | 56392 | 0.030 |
Why?
|
Enzyme Activation | 1 | 2008 | 3701 | 0.030 |
Why?
|
HeLa Cells | 1 | 2008 | 3130 | 0.030 |
Why?
|
Child | 2 | 2014 | 77637 | 0.030 |
Why?
|
In Situ Hybridization | 1 | 2016 | 1952 | 0.030 |
Why?
|
Tumor Microenvironment | 1 | 2024 | 3583 | 0.020 |
Why?
|
Lymph Nodes | 1 | 2023 | 3476 | 0.020 |
Why?
|
Protein Structure, Tertiary | 1 | 2008 | 3847 | 0.020 |
Why?
|
Lymphatic Metastasis | 1 | 2019 | 2924 | 0.020 |
Why?
|
Sex Distribution | 1 | 2016 | 2298 | 0.020 |
Why?
|
Multicenter Studies as Topic | 1 | 2015 | 1676 | 0.020 |
Why?
|
Health Personnel | 1 | 2023 | 3217 | 0.020 |
Why?
|
Comorbidity | 1 | 2014 | 10380 | 0.020 |
Why?
|
Age Distribution | 1 | 2016 | 2899 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2015 | 2883 | 0.020 |
Why?
|
ROC Curve | 1 | 2017 | 3527 | 0.020 |
Why?
|
Patient Discharge | 1 | 2021 | 3317 | 0.020 |
Why?
|
Immunotherapy | 1 | 2024 | 4437 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2016 | 3547 | 0.020 |
Why?
|
Regression Analysis | 1 | 2018 | 6457 | 0.020 |
Why?
|
Length of Stay | 1 | 2021 | 6311 | 0.020 |
Why?
|
Academic Medical Centers | 1 | 2018 | 2760 | 0.020 |
Why?
|
Base Sequence | 1 | 2008 | 12798 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2019 | 8637 | 0.020 |
Why?
|
Amino Acid Sequence | 1 | 2008 | 13809 | 0.020 |
Why?
|
Repressor Proteins | 1 | 2017 | 3024 | 0.020 |
Why?
|
Molecular Sequence Data | 1 | 2008 | 18107 | 0.020 |
Why?
|
Reproducibility of Results | 1 | 2023 | 19894 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 2016 | 5867 | 0.020 |
Why?
|
Multivariate Analysis | 1 | 2018 | 12243 | 0.010 |
Why?
|
Cell Line | 1 | 2008 | 15993 | 0.010 |
Why?
|
Databases, Factual | 1 | 2018 | 7729 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2018 | 14714 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2016 | 8430 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2016 | 16674 | 0.010 |
Why?
|
Mice | 1 | 2016 | 81154 | 0.010 |
Why?
|
Animals | 1 | 2016 | 168660 | 0.000 |
Why?
|
Concepts
(219)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(57)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_